ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 2, 2005, Pages 300-304

  Larsen, T Bjerregaard ^a,b   Johnsen, S P ^b   Gislum, M ^b   Moller C A I ^b   Larsen, H ^c   Sorensen H T ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

ABO blood group; Pregnancy; The puerperium; Thrombophilia; Venous thromboembolism

Indexed keywords

ADULT; ARTICLE; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP ABO SYSTEM; BLOOD GROUP B; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; LUNG EMBOLISM; POPULATION RESEARCH; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PUERPERIUM; VENOUS THROMBOEMBOLISM; BLOOD; CASE CONTROL STUDY; PHYSIOLOGY; PREDICTION AND FORECASTING; RISK; RISK ASSESSMENT; THROMBOEMBOLISM; VEIN THROMBOSIS;

ABO BLOOD-GROUP SYSTEM; ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; ODDS RATIO; POSTPARTUM PERIOD; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK ASSESSMENT; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 20844461362     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01195.x     Document Type: Article

References (22)

1. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999; 353: 1258-65.
2. Eldor A. Thrombophilia, thrombosis and pregnancy. Thromb Haemost 2001; 86: 104-11.
3. Martinelli ISV, Taioli E, Paciaroni K, Rossi E, Mannucci PM. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost 2002; 87: 791-5.
4. Danilenko-Dixon DR, Heit JA, Silverstein MD, Yawn BP, Petterson TM, Lohse CM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case-control study. Am J Obstet Gynecol 2001; 184: 104-10.
5. Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 2001; 86: 395-403.
6. Grandone E, Margaglione M, Colaizzo D, D'Andrea G, Cappucci G, Brancaccio V, Di Minno G. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol 1998; 179: 1324-8.
7. Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost 2001; 86: 800-3.
8. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk, opportunities for intervention and screening? BMJ 2002; 325: 157-60.
9. Jick H, Slone D, Westerholm B, Inman WH, Vessey MP, Shapiro S, Lewis GP, Worcester J. Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1969; 1: 539-42.
10. Talbot S, Wakley EJ, Ryrie D, Langman MJ. ABO blood-groups and venous thromboembolic disease. Lancet 1970; 1: 1257-9.
11. Sørensen HT, Schulze S. Danish health registries. A valuable tool in medical research. Dan Med Bull 1996; 43: 463.
12. Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 263-8.
13. Roy PM, Barbeau C, Ternisien C, Leftheriotis G. Diagnostic strategy in deep-vein thrombosis. Lancet 1998; 351: 1588.
14. Perrier A, Bounameaux H, Morabia A, de Moerloose P, Slosman D, Didier D, Unger P-F, Junod A. Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography: a management study. Arch Intern Med 1996; 156: 531-6.
15. Hill H, Loudon NB, Pitcher CS, Pocock VM. Venous thromboembolic disease and ABO blood type. Lancet 1969; 1: 623.
16. Morelli VM, De Visser MCH, Vos HL, Bertina RM, Rosendaal FR. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost 2004; Early online publication 17 November 2004.
17. Larsen TB, Lassen JF, Brandslund I, Byriel L, Bruun Petersen G, Nørgaard-Pedersen B. The Arg506Gln mutation (FV-Leiden) among a cohort of 4,188 unselected Danish newborns. Thromb Res 1998; 89: 211-5.
18. Dizon-Townson DS, Nelson LM, Jang H, Varner MW, Ward K. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis. Am J Obstet Gynecol 1997; 176: 883-6.
19. Kupfermine MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340:9-13.
20. Robert A, Aillaud MF, Eschwege V, Randrianjohany A, Scarabin Y, Juhan-Vague I. ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden. Thromb Haemost 2000; 83: 630-1.
21. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-5.
22. Souto JC, Almasy L, Muniz-Diaz E, Soria JM, Borrell M, Bayen L, Mateo J, Madoz P, Stone W, Blangero J, Fontcuberta J. Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 2000; 20: 2024-8.